Form D · Other Technology

Pivot Bio, Inc.

Berkeley, CA · CIK 0001623627

Offering snapshot reported Aug 4, 2021 · SEC filing

Reported sold
$435M
Offering amount: $435M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 4, 2021Initial$434,539,674No comparisonNot reportedSEC filing
May 12, 2020Initial$100,000,000No comparison13SEC filing
Oct 29, 2018Initial$71,330,743No comparison15SEC filing
Mar 22, 2016Amendment$15,996,489$7,874,980vs Jan 22, 201610SEC filing
Jan 22, 2016Initial$8,121,509No comparison4SEC filing
Oct 30, 2014Initial$749,998No comparison1SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-408715

Source: Form D, filed Aug 4, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher Abbott Director
John Hamer Director
Dheeraj Mehta Director
Matt Ocko Director
Ryan Rakestraw Director
Charles Cooper Rinzler Director
Lisa Safarian Director
Alvin Tamsir Director, Executive
Karsten Temme Director, Executive
Roger Wyse Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
2910 Seventh St.
Berkeley, CA, 94710